<code id='93A0C0325D'></code><style id='93A0C0325D'></style>
    • <acronym id='93A0C0325D'></acronym>
      <center id='93A0C0325D'><center id='93A0C0325D'><tfoot id='93A0C0325D'></tfoot></center><abbr id='93A0C0325D'><dir id='93A0C0325D'><tfoot id='93A0C0325D'></tfoot><noframes id='93A0C0325D'>

    • <optgroup id='93A0C0325D'><strike id='93A0C0325D'><sup id='93A0C0325D'></sup></strike><code id='93A0C0325D'></code></optgroup>
        1. <b id='93A0C0325D'><label id='93A0C0325D'><select id='93A0C0325D'><dt id='93A0C0325D'><span id='93A0C0325D'></span></dt></select></label></b><u id='93A0C0325D'></u>
          <i id='93A0C0325D'><strike id='93A0C0325D'><tt id='93A0C0325D'><pre id='93A0C0325D'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:13
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          House panel to mark up pandemic
          House panel to mark up pandemic

          HouseEnergy&CommerceChairCathyMcMorrisRodgers(R-Wash.)KevinDietsch/GettyImagesWASHINGTON—AHouses

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Drinking water from half of US faucets contains PFAS: Study

          CoryMorse/TheGrandRapidsPressviaAPDrinkingwaterfromnearlyhalfofU.S.faucetslikelycontains“foreverchem